PE20050901A1 - COMBINATION OF AMLODIPINE AND ATENOLOL IN THE PHARMACEUTICAL FORM OF CAPSULE - Google Patents

COMBINATION OF AMLODIPINE AND ATENOLOL IN THE PHARMACEUTICAL FORM OF CAPSULE

Info

Publication number
PE20050901A1
PE20050901A1 PE2004001213A PE2004001213A PE20050901A1 PE 20050901 A1 PE20050901 A1 PE 20050901A1 PE 2004001213 A PE2004001213 A PE 2004001213A PE 2004001213 A PE2004001213 A PE 2004001213A PE 20050901 A1 PE20050901 A1 PE 20050901A1
Authority
PE
Peru
Prior art keywords
atenolol
amlodipine
capsule
pharmaceutical form
combination
Prior art date
Application number
PE2004001213A
Other languages
Spanish (es)
Inventor
Omilton Visconde Jr
Original Assignee
Biosintetica Farmaceutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosintetica Farmaceutica Ltda filed Critical Biosintetica Farmaceutica Ltda
Publication of PE20050901A1 publication Critical patent/PE20050901A1/en

Links

Abstract

REFERIDA A UNA COMBINACION FARMACEUTICA BAJO LA FORMA FARMACEUTICA DE CAPSULA CUYOS PRINCIPIOS ACTIVOS SON: A) UN ANTAGONISTA DE LOS CANALES DE CALCIO COMO AMLODIPINA, Y B) UN BETABLOQUEADOR TAL COMO ATENOLOL GRANULADO QUE SE HALLA DENTRO DE UNA CAPSULA DE GELATINA DURA. A Y B SE HALLAN EN LA COMPOSICION DE 5-20 mg Y DE 20-100 mg RESPECTIVAMENTE. DICHA COMPOSICION ES UTIL EN LA HIPERTENSION ARTERIAL Y EN LA INSUFICIENCIA CORONARIA CRONICA ESTABLEREFERRING TO A PHARMACEUTICAL COMBINATION IN THE PHARMACEUTICAL FORM OF CAPSULE WHOSE ACTIVE PRINCIPLES ARE: A) AN ANTAGONIST OF CALCIUM CHANNELS SUCH AS AMLODIPINE, AND B) A BETABLOCKER SUCH AS ATENOLOL GRANULATED THAT IS FOUND INSIDE A GATIN CAPSULA. A AND B ARE IN THE COMPOSITION OF 5-20 mg AND 20-100 mg, RESPECTIVELY. SUCH COMPOSITION IS USEFUL IN ARTERIAL HYPERTENSION AND IN STABLE CHRONIC CORONARY INSUFFICIENCY

PE2004001213A 2003-12-09 2004-12-09 COMBINATION OF AMLODIPINE AND ATENOLOL IN THE PHARMACEUTICAL FORM OF CAPSULE PE20050901A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0304956-6A BR0304956A (en) 2003-12-09 2003-12-09 Pharmaceutical combination in a new pharmaceutical form useful in hypertension and chronic stable coronary insufficiency

Publications (1)

Publication Number Publication Date
PE20050901A1 true PE20050901A1 (en) 2005-12-16

Family

ID=35295191

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004001213A PE20050901A1 (en) 2003-12-09 2004-12-09 COMBINATION OF AMLODIPINE AND ATENOLOL IN THE PHARMACEUTICAL FORM OF CAPSULE

Country Status (6)

Country Link
AR (1) AR046876A1 (en)
BR (1) BR0304956A (en)
CO (1) CO5650066A1 (en)
EC (1) ECSP045478A (en)
MX (1) MXPA04012380A (en)
PE (1) PE20050901A1 (en)

Also Published As

Publication number Publication date
BR0304956A (en) 2005-11-08
CO5650066A1 (en) 2006-06-30
MXPA04012380A (en) 2005-10-19
ECSP045478A (en) 2006-09-18
AR046876A1 (en) 2005-12-28

Similar Documents

Publication Publication Date Title
CR7074A (en) MERCAPTOACETYLAMIDA DERIVATIVES AND PROCESS FOR PREPARATION AND USE
DK1575566T3 (en) Multilayer dosage forms containing naproxen and triptans
BRPI0513841A (en) compound, pharmaceutical composition, and compound use
EA201070835A1 (en) COMPOSITION CAPSULES
CO6160321A2 (en) USE OF 2-6- (3-AMINO-PIPERIDIN-1-IL) -3-METIL-2,4-DIOXO-3,4-DIHIDRO-2H-PYRIMIDIN-1-ILMETIL-4-FLUORO-BENZONITRILE
CR9262A (en) FORMULATIONS IN TABLET OF CCI-1179 ORALY AVAILABLE
ECSP088549A (en) NEW DERIVATIVES OF FUSIONATED PIRROL
ECSP12006640A (en) ASPARTIL PROTEASA HETEROCYCLIC INHIBITORS
ECSP066534A (en) DOSAGE FORMS OF CONTROLLED OXYCODONE, ORALS, ONCE A DAY
HN2009000785A (en) DOSAGE FORMS OF PALONOSETRON CHLORHYDRATE THAT HAVE IMPROVED STABILITY AND BIODISPONIBILITY
PE20091809A1 (en) USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR MORTALITY
PA8809601A1 (en) ANTI-RETROVIRAL COMBINATION
EA201691869A1 (en) STABLE COMBINED PHARMACEUTICAL COMPOSITION
BR0009674A (en) Compound, drug and compound use
ECSP066872A (en) DISINTEGRANT TABLETS UNDERSTANDING LICARBAZEPINA
IS7394A (en) Stable drug formulations
PE20050901A1 (en) COMBINATION OF AMLODIPINE AND ATENOLOL IN THE PHARMACEUTICAL FORM OF CAPSULE
PE20110116A1 (en) ASSOCIATION OF IVABRADINE AND PERINDOPRIL AND THE PHARMACEUTICAL COMPOSITION CONTAINING IT
CL2012002341A1 (en) Oral solid pharmaceutical composition comprising ramipril and amlodipine besylate; preparation procedure; use in the treatment of hypertension and prevention of myocardial infarction, cerebrovascular and cardiac disorders and renal insufficiency.
CR9406A (en) DDGS AS A LOW COST FLAVOR ACUTOR AND SODIUM REDUCTION ENABLE
CR8948A (en) PHARMACEUTICAL COMPOSITION
AR050627A1 (en) PHARMACEUTICAL COMPOSITION
CR6505A (en) SUBSTITUTED BENZOLACTAMA COMPOUNDS
EA201291420A1 (en) ORAL MEDICAL FORMS CONTAINING LERCANIDIPIN AND ENALAPRIL AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
UY28857A1 (en) 17A (ALPHA) -FLUOROSTEROIDS

Legal Events

Date Code Title Description
FC Refusal